
Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease
Keywords: فاکتور نکروز تومور; Biologics; Real-World Effectiveness; Database Analysis; Propensity Matching; ADA; adalimumab; aHR; adjusted hazard ratio; CD; Crohn's disease; CI; confidence interval; CZP; certolizumab pegol; IBD; inflammatory bowel disease; ICD-9; International Classi